BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Diagnosis
8327 results:

  • 1. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
    Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
    Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
    PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Improvements in advanced hepatocellular carcinoma to repeat implementation of primary protocol after cancer progression occurs following sequential systemic therapy and a clinical trial: A case report.
    Huang H; Wei Q; Leng C; Wang H; Mei B
    Medicine (Baltimore); 2024 May; 103(19):e38138. PubMed ID: 38728500
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Applications of Pyrrole and Pyridine-based Heterocycles in cancer diagnosis and Treatment.
    Tyagi R; Yadav K; Srivastava N; Sagar R
    Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.
    Wang A; Wu J; Yuan X; Liu J; Lu C
    BMC Med Genomics; 2024 May; 17(1):124. PubMed ID: 38711024
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry.
    Klomberg RCW; Hellendoorn AE; Kemos P; Rizopoulos D; Ruemmele FM; Croft NM; de Ridder L;
    Lancet Child Adolesc Health; 2024 Jun; 8(6):422-432. PubMed ID: 38697175
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma.
    Zhu JQ; Liu JZ; Yang SW; Ren ZY; Ye XY; Liu Z; Li XL; Han DD; He Q
    Front Endocrinol (Lausanne); 2024; 15():1306091. PubMed ID: 38686208
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
    Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
    Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
    Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
    JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Primary hepatic sarcomatoid carcinoma, an unusual case].
    Rueda DA; Antinucci F; Amante MF; Bas CA
    Medicina (B Aires); 2024; 84(2):337-341. PubMed ID: 38683520
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
    Öztürk NB; Jamil LH
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.
    Tajima T; Martinez OM; Bernstein D; Boyd SD; Gratzinger D; Lum G; Sasaki K; Tan B; Twist CJ; Weinberg K; Armstrong B; Desai DM; Mazariegos GV; Chin C; Fishbein TM; Tekin A; Venick RS; Krams SM; Esquivel CO
    Pediatr Transplant; 2024 Jun; 28(4):e14763. PubMed ID: 38682750
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
    Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Utility of Cytokeratins for Accurate diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
    Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
    Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
    Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Retrospective analysis of the incidence of appendiceal neoplasm and malignancy in patients treated for suspected acute appendicitis.
    Dohner E; Kierdorf FJ; Langer R; Zuber M; Fahrner R
    BMC Surg; 2024 Apr; 24(1):121. PubMed ID: 38658891
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
    Chen TC; Hsiao SW; Chen YY; Yen HH; Su WW; Hsu YC; Huang SP; Su PY
    Sci Rep; 2024 Apr; 14(1):9068. PubMed ID: 38643245
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery.
    Sarofim M; Wijayawardana R; Ahmadi N; Barat S; Liauw W; Morris DL
    World J Surg Oncol; 2024 Apr; 22(1):103. PubMed ID: 38637820
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Re-188 lipiodol in hepatocellular carcinoma with portal vein thrombosis: a pilot study using novel chelating agent N-DEDC and its comparison with (A)HDD.
    Datta Gupta SS; Shamim SA; Gamanagatti S; Gupta P; Khan MA; Mallia MB; Chirayil V; Dash A; Bal C
    Nucl Med Commun; 2024 Jun; 45(6):510-518. PubMed ID: 38632971
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 417.